MDT vs RLAY · P/E 21, rev $36.36B vs rev $3.4M
Medtronic PLC (MDT) versus Relay Therapeutics Inc (RLAY) — a side-by-side from cached financials, not a winner call.
Medtronic PLC (MDT) is a medical devices company listed on US.
Relay Therapeutics Inc (RLAY) is a biotechnology company listed on NASDAQ.
Latest reported MDT revenue for 2026-04-24 was $36.36B. Net income was $4.80B. Revenue was up 8.4% from 2025-04-25 to 2026-04-24. MDT currently screens at market cap $100.08B and trailing P/E 20.9.
Latest reported RLAY revenue for 2026-06-30 was $3.4M. Net income was -$157.0M. Revenue was up 11.7% from 2026-03-31 to 2026-06-30. RLAY currently screens at market cap $3.39B.
MDT currently screens at market cap $100.08B and trailing P/E 20.9. RLAY currently screens at market cap $3.39B.
Not investment advice. Open the MDT and RLAY stock pages for the full models.
Not investment advice.